Growth factor stimulation appears to be a part of this “crosstalk” as epidermal growth factor (EGF) leads to epitheliomesenchymal transition-like changes in human breast cancer cells including upregulation of vimentin and downregulation of E-cadherin. Here, CDH1 is linked to breast cancer.